TREM1 highly expressed in myeloid cells, maintains the tumor inflammatory microenvironment via the NF-κB/IL-6/STAT3 pathway; it may also directly activate pro-survival signals within tumor cells (Ren et al., 2024) (e.g., PI3K-AKT). Here, NFKB1 is linked to neoplasm.